Supplementary Table. Relative COVID-19 Vaccine Effectiveness Against Laboratory-Confirmed COVID-19–Associated Hospitalizations and Critical Illness† Among Adults Aged ≥18 Years Who Received a Bivalent Vaccine Dose Compared With Adults Aged ≥18 Years Who Received Monovalent Doses Only, by Age Group and Immunocompromise Status — Seven States, September 2022–April 2023
CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners. As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
i

Supplementary Table. Relative COVID-19 Vaccine Effectiveness Against Laboratory-Confirmed COVID-19–Associated Hospitalizations and Critical Illness† Among Adults Aged ≥18 Years Who Received a Bivalent Vaccine Dose Compared With Adults Aged ≥18 Years Who Received Monovalent Doses Only, by Age Group and Immunocompromise Status — Seven States, September 2022–April 2023



English

Details:

You May Also Like

Checkout today's featured content at stacks.cdc.gov